key: cord-0887314-tvatgon1
authors: Li, Shuwen; Ren, Jiahao; Hou, Hongjie; Han, Xueya; Xu, Jie; Duan, Guangcai; Wang, Yadong; Yang, Haiyan
title: The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates
date: 2022-03-24
journal: Neurol Sci
DOI: 10.1007/s10072-022-06024-9
sha: d7625a04b19ee4a7a389d4b1f1ce2093d65c7ee5
doc_id: 887314
cord_uid: tvatgon1

OBJECTIVE: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients. METHODS: We performed systematic searches through electronic databases including PubMed, Embase, Scopus, and Web of Science to identify potential articles reporting adjusted effect estimates on the association of stroke with COVID-19-related mortality. To estimate pooled effects, the random-effects model was applied. Subgroup analyses and meta-regression were performed to explore the possible sources of heterogeneity. The stability of the results was assessed by sensitivity analysis. Publication bias was evaluated by Begg’s test and Egger’s test. RESULTS: This meta-analysis included 47 studies involving 7,267,055 patients. The stroke was associated with higher COVID-19 mortality (pooled effect = 1.30, 95% confidence interval (CI): 1.16–1.44; I(2) = 89%, P < 0.01; random-effects model). Subgroup analyses yielded consistent results among area, age, proportion of males, setting, cases, effect type, and proportion of severe COVID-19 cases. Statistical heterogeneity might result from the different effect type according to the meta-regression (P = 0.0105). Sensitivity analysis suggested that our results were stable and robust. Both Begg’s test and Egger’s test indicated that potential publication bias did not exist. CONCLUSION: Stroke was independently associated with a significantly increased risk for mortality in COVID-19 patients.

A series of studies have explored the relationship between comorbid stroke and the risk of mortality in coronavirus disease 2019 (COVID- 19) , but the conclusions were inconsistent or conflicting. Two previous meta-analyses on the basis of un-adjusted effect estimates failed to observe that comorbid stroke was significantly related to an increased risk of mortality in COVID-19 patients [1, 2] . To our knowledge, several risk factors including age, gender, and other underlying conditions (diabetes, hypertension, chronic kidney disease, and chronic obstructive pulmonary disease and others) have been reported to have a significant impact on the clinical progression of patients with COVID-19 [3] [4] [5] [6] [7] [8] . This meant that these factors might affect the association between stroke and COVID-19 mortality. For example, the results of univariate analysis in Muhammad et al.'s study [9] showed that stroke was a risk factor for the mortality of COVID-19 (odds ratio (OR) = 2.73, 95% confidence interval (CI): 1.08-6.88), while the results of multivariate analysis demonstrated that stroke was not significantly associated with COVID-19 mortality (adjusted OR = 1.34, 95% CI: 0. 45-4.02) . Similar findings were also observed by Lee et al. [10] . Therefore, a meta-analysis based on adjusted effect estimates was performed to investigate the association of stroke with fatal outcome in COVID-19 patients.

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist was used to improve the reporting of this meta-analysis. Databases including PubMed, Web of Science, Scopus, and Embase were searched up to November 22, 2021 , to find the relevant studies. The following search terms were used: ("COVID-19" OR "coronavirus disease 2019" OR "SARS-CoV-2" OR "novel coronavirus" OR "2019-nCoV") AND ("stroke" OR "strokes" OR "cerebral stroke" OR "acute cerebrovascular accident" OR "cerebral infarction") AND ("mortality" OR "death" OR "fatality" OR "deceased" OR "non-survivor"). Moreover, to find more grey literature on this topic, relevant references of the included studies were also taken into account.

The following inclusion criteria were defined for the selection of the papers: (1) articles should be published in English; (2) COVID-19 patients were diagnosed according to the World Health Organization (WHO) standards;

(3) articles reported adjusted effect estimates on the association between stroke and the risk of mortality among COVID-19 patients. Repeated articles, case reports, reviews, comments, protocols, errata, and articles without sufficient information were excluded. Only the articles with the most complete data could be included if studies were based on the same data sources.

Two authors selected eligible studies independently and screened the titles and abstracts on the basis of the inclusion criteria. Any disagreement would be resolved through discussion. The primary message included the following data: author, country, cohort type, cases, numbers Meta-analysis was performed using the R statistical software (Version 4.1.1, The R Foundation, Vienna, Austria) with "meta" package (Version 4.19-0) to calculate the pooled effect and 95% CI on the association between stroke and COVID-19 mortality. The I 2 statistic was used to assess heterogeneity, which was considered significant if I 2 > 50%. A random-effects model was adopted if heterogeneity was significant; otherwise, a fixed-effects model would be implemented. Subgroup analyses were conducted according to the area, age, cohort type, effect type, setting, cases, proportion of severe COVID-19 cases, and the proportion of males to explore the sources of heterogeneity. The robustness of the results was tested using sensitivity analysis by eliminating data one at a time. The authors also used the Begg's and Egger's tests to detect publication bias. Statistically significant difference was considered when P value was less than 0.05.

The literature search identified 4252 articles through database mining. A total of 4177 of them were excluded after screening the titles and abstracts, and 75 reports were reviewed for full-text evaluation. As a result, we included 47 studies of 7,267,055 patients . A flowchart of the study search and selection was shown in Fig. 1 . Basic characteristics of the included studies were presented in Table 1 .

Overall, comorbid stroke was significantly linked to an increased risk of mortality in patients with COVID-19 (pooled effect = 1.30, 95% CI: 1.16-1.44, random-effects model, Fig. 2 ). This significant association was also observed in the subgroup analyses based on cases ( Table 2 ). As we implemented subgroup analysis by cohort type, the association was still significant in the subgroups of retrospective studies (44 studies, pooled effect = 1.27, 95% CI: 1.14-1.42) and ambispective study (1 study, pooled effect = 3.70, 95% CI: 1.08-12.67), while no significant association was found in the subgroup of prospective studies (2 studies, pooled effect = 2.96, 95% CI: 0.45-19.31) ( Table 2) .

And the outputs of meta-regression demonstrated that effect type might be the source of heterogeneity (P = 0.0105) ( Table 2 ). Sensitivity analysis by omitting each eligible study one by one demonstrated that our findings were stable and robust (Fig. 3) . Publication bias was not found in the Begg's test (P = 0.0864) and Egger's test (P = 0.8776) (Fig. 4) . 

Two previous meta-analyses did not observe the significant relationship between comorbid stroke and the increased risk of mortality in COVID-19 patients on the basis of un-adjusted effect estimates [1, 2] . In order to exclude the influence of factors such as gender, age, and comorbidities, we conducted a meta-analysis of 47 articles involving 7,267,055 patients that contained the results of multivariate analysis. The results showed that comorbid stroke was significantly associated with an increased risk of mortality in COVID-19 patients on the basis of confounders-adjusted effect estimates, which demonstrated that stroke might be an independent risk factor for COVID-19-related mortality. The outputs of subgroup analyses stratified by age, proportion of male patients, area, cases, setting, effect type, and proportion of severe COVID-19 infection were in consistence with the conclusion above. According to the results of metaregression, heterogeneity may originate from the different effect indicators used in the included studies. Stroke has been confirmed increasing the risk of pulmonary complications like pneumonia, which could lead to the fatal outcome of COVID-19 patients [56] [57] [58] . It might par tly explain why COVID-19 patients with stroke displayed a higher mortality in our analysis. From another perspective, infection was a vital risk factor for stroke, especially systemic upper respiratory disease [59, 60] . The spike protein surface unit of SARS-CoV-2 highly binds to human ACE-2 receptor, which affects the normal physiological function of the ACE-2 to degrade ANG II , causing neuronal damage and endothelial cell apoptosis [61] . The dysfunction of endothelial cell, leading to fibrinolysis inhibition and excessive thrombin production [62] , plays an important role in the occurrence of thrombotic events [63] . The human immune system will produce amounts of proinf lammatory cytokines such as interleukin (IL)-1β, tumor necrosis factor-alpha (TNF-α), and IL-6 when SARA-CoV-2 infects the body [64] . This phenomenon referred to as "cytokine storm" results in the degradation of the extracellular matrix (ECM), which is responsible for maintaining the integrity and stability of vascular endothelial cells. Degradation of the ECM contributes to the extravasation of blood components, and leads to hemorrhagic brain injury [65] . Worse still, stroke patients suffering from COVID-19 were more susceptible to undesirable outcomes and greater mortality rates compared with those without [66, 67] . A higher risk of large vessel occlusion and hemorrhagic transformation among ischemic stroke patients with COVID-19, combined with COVID-19 patients being more prone to intracerebral hemorrhage, might contribute to this difference [68] [69] [70] . Previous study has shown a past history of cerebrovascular disease might be associated with an increased stroke risk in COVID-19 patients [71] . Thus, we suspected that patients with a history of stroke are more likely to trigger above-mentioned mechanisms, leading to higher mortality of COVID-19 patients with preexisting stroke. During clinical treatment, more attention should be paid to the possible two-way relationship between stroke and COVID-19 infection. However, several limitations should be acknowledged. First, our study was limited due to lack of explanation of how stroke was defined in the literature and therefore we could not explore the relationship between different stroke types and COVID-19 mortality. Furthermore, it needs to be acknowledged that most of the selected articles were retrospective observational studies, which were not able to completely explain the casual link between the stroke and COVID-19 mortality, implying that more prospective studies with larger samples are necessary to verify the findings. Lastly, the pooled effects were estimated based on risk factors-adjusted effects, but the adjusted risk factors were not fully consistent across the included researches.

In conclusion, our data indicated that stroke was related to a significantly increased risk for COVID-19 mortality. These findings were supposed to provide a basis for risk scales in the care of patients with COVID-19 in emergency services or intensive care units. 

Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis

Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature

The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates

Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions

COVID-19 Clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis

The association of cerebrovascular disease with adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates

The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates

Autoimmune diseases are independently associated with COVID-19 severity: evidence based on adjusted effect estimates

Clinical characteristics and predictors of mortality in minority patients hospitalized with COVID-19 infection

Prognostic impact of atrial fibrillation in patients with severe acute respiratory syndrome coronavirus 2 infection

The swedish covid-19 intensive care cohort: Risk factors of ICU admission and ICU mortality

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study

Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a cross-sectional study

Age and multimorbidities as poor prognostic factors for COVID-19

Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort

Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study

Characteristics and outcomes of patients hospitalized for COVID-19 in France: the Critical COVID-19 France (CCF) study

Latash (2021) Risk Factors for death among hospitalized patients aged 21-64 years diagnosed with COVID-19

Investigators C-C (2021) Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection

One-year mortality and consequences of COVID-19 in cancer patients: a cohort study

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

I (2020) consortium, contributors, Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data

Myocardial injury in hospitalized patients with COVID-19 infection-risk factors and outcomes

Neurologic syndromes predict higher in-hospital mortality in COVID-19

CSAPG (2022) COVID-19: clinical presentation and prognostic factors of severe disease and mortality in the oldest-old population: a cohort study

Izquierdo (2020) Characteristics and prognosis of COVID-19 in patients with COPD

Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: a report from the SEUS Study Group

Baysal (2021) The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19

Association of social and behavioral risk factors with mortality among US veterans with COVID-19

History of stroke is independently associated with in-hospital death in patients with COVID-19

High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study

Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome

Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality

The impact of sociodemographic factors, comorbidities, and physiologic responses on 30-day mortality in coronavirus disease 2019 (COVID-19) patients in metropolitan detroit

Jesmajian S (2020) Incidence and risk factors for acute kidney injury and its effect on mortality in patients hospitalized from COVID-19

Tezenas du Montcel, V. Gilleron (2020) Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database

History of heart failure in patients with coronavirus disease 2019: Insights from a French registry

Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic London national health service trust: a retrospective cohort study

Outcomes of patients with COPD hospitalized for coronavirus disease 2019

Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort

Renin-angiotensin system inhibitors and mortality in patients with COVID-19

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people

Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh. Saudi Arabia

Characteristics and risk factors associated with mortality in critically ill patients with COVID-19

Vashishth (2021) Evaluation and management of COVID-19-related severity in people with type 2 diabetes

J-waves in acute COVID-19: a novel disease characteristic and predictor of mortality?

Population-based assessment of risks for severe COVID-19 disease outcomes

Investigators (2022) Evaluation of central venous catheter and other risk factors for mortality in chronic hemodialysis patients with COVID-19 in Brazil

Group (2022) Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

Risk factors for COVID-19 deaths among elderly nursing home medicare beneficiaries in the prevaccine period

Myklebust Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection?

Mortality of COVID-19 patients with vascular thrombotic complications

Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong

Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19

The global burden of stroke: persistent and disabling

One-year risk of pneumonia and mortality in patients with poststroke dysphagia: a nationwide population-based study

Long-term neurological, vascular, and mortality outcomes after stroke

Risk of myocardial infarction and stroke after acute infection or vaccination

Influenza-like illness as a trigger for ischemic stroke

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression

HIV-Associated venous thromboembolism

The stimulation of thrombosis by hypoxia

Cytokine storm induced by SARS-CoV-2

Vascular dysfunction in brain hemorrhage: translational pathways to developing new treatments from old targets

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

SARS-CoV-2 and stroke in a New York healthcare system

Krogias C (2021) COVID-19: neuroimaging features of a pandemic

Stroke in COVID-19: a systematic review and meta-analysis

Acute cerebrovascular events with COVID-19 infection

Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis

We would like to thank Ruiying Zhang, Mengke